$SCLN - SciClone Pharmaceuticals Reaffirms Above Estimates

SciClone Pharmaceuticals Inc. said it continues expect 2014 non-GAAP earnings of $0.64 to $0.68 per share on revenue of $130.0 million to $135.0 million. The current consensus earnings estimate is $0.56 per share on revenue of $132.3 million for the year ending December 31, 2014. The company also said it expects 2015 revenue of $153.0 million to $158.0 million. The current consensus estimate is revenue of $156.5 million for the year ending December 31, 2015.